Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). <i>Vaccines</i> 2023, <i>11</i>, 1374

Abstract

The authors would like to make the following corrections to this published paper [...]

Keywords

• n/a